Lineage Cell Therapeutics, Inc. (LCTX)
↓ Download CSV- Sector Manufacturing
- Incorporated CA
- Fiscal year ends Dec 31
In fiscal 2025, Lineage Cell Therapeutics, Inc. reported revenue of $14.56M, up 53.2% from the prior year. The company ran a net loss, with a net margin of -436.5%. It held $112.58M in total assets against $69.24M in total liabilities.
Key ratios (FY2025)
-251.6%
Operating margin
-436.5%
Net margin
-146.6%
Return on equity
+53.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.56M | $9.50M | $8.95M | $14.70M | $4.34M | $1.83M | — | — | — | — |
| Cost of Revenue | — | $334.0K | $671.0K | $728.0K | $1.43M | $385.0K | $412.0K | $302.0K | $168.0K | $358.0K |
| Gross Profit | — | — | $8.27M | $13.97M | $2.92M | $1.44M | $3.10M | $4.69M | $3.29M | $5.57M |
| Operating Income | -$36.62M | -$21.48M | -$24.73M | -$22.52M | -$49.21M | -$26.45M | -$38.88M | -$41.80M | -$38.90M | -$58.97M |
| Net Income | -$63.53M | -$18.61M | -$21.49M | -$26.27M | -$43.02M | -$20.65M | -$11.71M | -$45.99M | -$19.98M | $33.57M |
| EPS (Diluted) | $-0.28 | $-0.09 | $-0.12 | $-0.15 | $-0.26 | — | — | — | $-0.17 | $0.35 |
| Total Assets | $112.58M | $113.22M | $101.02M | $123.66M | $174.54M | $107.95M | $125.48M | $101.66M | $173.24M | $142.57M |
| Total Liabilities | $69.24M | $36.21M | $39.00M | $51.73M | $83.65M | $12.82M | $14.23M | $9.41M | $8.98M | $12.06M |
| Shareholders' Equity | $43.35M | $77.01M | $62.02M | $71.94M | $90.90M | $95.13M | $111.25M | $92.25M | $164.26M | $130.51M |
| Cash & Equivalents | $40.79M | $45.79M | $35.44M | $11.36M | $55.74M | $32.59M | $9.50M | $23.59M | $36.84M | $22.09M |
| Operating Cash Flow | -$18.92M | -$23.09M | -$28.57M | $1.06M | -$23.56M | -$19.75M | -$31.95M | -$30.88M | -$30.52M | -$42.33M |
| Capital Expenditures | $522.0K | $565.0K | $674.0K | $413.0K | $340.0K | $64.0K | $440.0K | $556.0K | $1.33M | $2.25M |
| Shares Outstanding | 243.12M | 220.42M | 174.99M | 170.09M | 169.48M | 153.10M | 149.80M | 127.14M | 126.87M | 102.78M |